Gen-Probe, Inc.
This article was originally published in The Gray Sheet
Executive Summary
Names Henry L. Nordhoff president and CEO, replacing Tom Bologna, who resigned on Dec. 31, 1993 to pursue new business opportunities. Nordhoff was previously president and CEO of TargeTech, Inc., a Connecticut-based subsidiary of Immune Response Corporation. In addition, Naoyo Saishu is named COO of Gen-Probe. Saishu, who had been executive VP, corporate development, since September 1993, will continue to serve as president of fellow Chugai subsidiary Chugai Pharma U.S.A
You may also be interested in...
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.
Roche Gets Adjuvant ALK+ Lung Cancer To Itself With Alecensa Approval
The US FDA cleared Roche’s supplemental approval request for ALK inhibitor Alecensa in ALK-positive non-small cell lung cancer following tumor resection.